Clinical Trial: Famvir for Treatment of Hearing in Unilateral Meniere's Disease
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Treatment of Hearing Fluctuation in Unilateral Meniere's Disease: A Randomized, Placebo-controlled Clinical Trial of Famciclovir
Brief Summary: The specific aim of this study is to determine the efficacy of treatment with famciclovir in unilateral Meniere's Disease patients, specifically whether hearing can be improved. The investigators will determine the percentage of unilateral Meniere's Disease patients experiencing an absence of hearing fluctuation after 3 months of treatment with famciclovir as compared to the placebo arm.
Detailed Summary:
Sponsor: House Research Institute
Current Primary Outcome: Pure-tone threshold change [ Time Frame: 3 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Tinnitus and/or dizziness handicap change [ Time Frame: 3 months ]
Original Secondary Outcome: Same as current
Information By: House Research Institute
Dates:
Date Received: January 31, 2012
Date Started: December 2011
Date Completion:
Last Updated: August 27, 2015
Last Verified: October 2013